APA (7th ed.) Citation

Jänne, P. A., von Pawel, J., Cohen, R. B., Crino, L., Butts, C. A., Olson, S. S., . . . Bonomi, P. D. (2007). Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer. Journal of clinical oncology, 25(25), 3936-3944. https://doi.org/10.1200/JCO.2007.11.1336

Chicago Style (17th ed.) Citation

Jänne, Pasi A., et al. "Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer." Journal of Clinical Oncology 25, no. 25 (2007): 3936-3944. https://doi.org/10.1200/JCO.2007.11.1336.

MLA (9th ed.) Citation

Jänne, Pasi A., et al. "Multicenter, Randomized, Phase II Trial of CI-1033, an Irreversible Pan-ERBB Inhibitor, for Previously Treated Advanced Non–Small-Cell Lung Cancer." Journal of Clinical Oncology, vol. 25, no. 25, 2007, pp. 3936-3944, https://doi.org/10.1200/JCO.2007.11.1336.